Listed

TherapeuticsMD, Inc.

TXMDNasdaqCIK 25743HealthcareFiscal year ends Dec 31

Reports and events: 392 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

TherapeuticsMD, Inc., Reports and events
FiledFormWhat it isAccession number
2019-08-0616:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-005793
2019-07-0906:57 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-004898
2019-06-2116:22 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001387131-19-004542
2019-06-1014:28 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-004327
2019-06-0707:15 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-004260
2019-05-1507:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-003624
2019-05-0817:02 ET10-QQuarterly reportPeriod 2019-03-310001387131-19-003457
2019-05-0616:07 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-003362
2019-04-3021:04 ETDEF 14AProxy statementPeriod 2019-06-200001387131-19-003116
2019-04-2516:33 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 2.04 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-002928
2019-04-1716:08 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 2.04 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-002719
2019-04-0807:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-002554
2019-03-1207:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-001840
2019-02-2718:45 ET10-KAnnual reportPeriod 2018-12-310001387131-19-001471
2019-02-2116:09 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-001384
2019-02-0407:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-000777
2019-01-0919:12 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-000127
2019-01-0807:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-19-000111
2018-12-1806:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-006811
2018-11-2706:49 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-006378
2018-11-1306:49 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-006073
2018-11-0807:01 ET10-QQuarterly reportPeriod 2018-09-300001387131-18-005976
2018-11-0716:08 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-005954
2018-10-2906:04 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-005702
2018-10-0207:00 ET8-K7.01 Regulation FD disclosure0001387131-18-005143
2018-09-2716:05 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-005012
2018-09-2407:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-004910
2018-09-0507:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-004474
2018-08-2106:46 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-004119
2018-08-1306:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-003883
2018-08-0309:28 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-237291
2018-07-3006:15 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-003402
2018-07-3006:04 ET10-QQuarterly reportPeriod 2018-06-300001387131-18-003401
2018-06-2617:00 ET8-K5.07 Shareholder vote results0001387131-18-002850
2018-06-0716:05 ET8-K2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-002560
2018-06-0409:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-002489
2018-05-3006:01 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-002408
2018-05-0716:35 ET10-QQuarterly reportPeriod 2018-03-310001387131-18-001945
2018-05-0316:11 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-001909
2018-04-2717:04 ETDEF 14AProxy statementPeriod 2018-06-250001387131-18-001815
2018-04-1620:06 ETSC 13D/AOwnership report, active investor, amended0001387131-18-001600
2018-04-1106:03 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-001522
2018-04-0207:01 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-001328
2018-03-1207:00 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-001037
2018-03-0817:23 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-001009
2018-02-2317:00 ET10-KAnnual reportPeriod 2017-12-310001387131-18-000776
2018-02-2016:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001387131-18-000732
2018-02-1417:23 ETSC 13D/AOwnership report, active investor, amended0001387131-18-000665
2018-01-0906:45 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-18-000105
2017-12-1916:44 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001387131-17-005903

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:24 ET. Listed shows no prices and gives no investment advice.